Your browser doesn't support javascript.
loading
Dummy run quality assurance study in the Korean Radiation Oncology Group 19 - 09 multi-institutional prospective cohort study of breast cancer.
Kim, Myeongsoo; Park, Boram; Kim, Haksoo; Kim, Yeon-Joo; Choi, Dong Ju; Chung, Weonkuu; Kim, Yeon Joo; Shin, Hyun Soo; Im, Jung Ho; Suh, Chang-Ok; Kim, Jin Hee; Ha, Boram; Kim, Mi Young; Park, Jongmoo; Lee, Jeongshim; Ahn, Sung-Ja; Lee, Sun Young; Kusumawidjaja, Grace; Lim, Faye; Cho, Won Kyung; Kim, Haeyoung; Choi, Doo Ho; Park, Won.
Afiliação
  • Kim M; Department of Radiation Oncology, National Cancer Center, Goyang, Korea.
  • Park B; Biomedical Statistics Center, Samsung Medical Center, Seoul, Korea.
  • Kim H; Department of Radiation Oncology, National Cancer Center, Goyang, Korea. haksoo.kim@ncc.re.kr.
  • Kim YJ; Department of Radiation Oncology, National Cancer Center, Goyang, Korea. yjkim1785@ncc.re.kr.
  • Choi DJ; Proton Therapy Center, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, 410-769, Goyang-si, Gyeonggi-do, Republic of Korea. yjkim1785@ncc.re.kr.
  • Chung W; Department of Radiation Oncology, National Cancer Center, Goyang, Korea.
  • Kim YJ; Radiation Oncology Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, Korea.
  • Shin HS; Department of Radiation Oncology, Kangwon National University Hospital, Chuncheon, Korea.
  • Im JH; Department of Radiation Oncology, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
  • Suh CO; Department of Radiation Oncology, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
  • Kim JH; Department of Radiation Oncology, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
  • Ha B; Department of Radiation Oncology, Keimyung University Dongsan Medical Center, Daegu, Korea.
  • Kim MY; Department of Radiation Oncology, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea.
  • Park J; Department of Radiation Oncology, Kyungpook National University Chilgok Hospital, Daegu, Korea.
  • Lee J; Department of Radiation Oncology, School of Medicine, Kyungpook National University, Daegu, Korea.
  • Ahn SJ; Department of Radiation Oncology, Inha University Hospital, Incheon, Korea.
  • Lee SY; Department of Radiation Oncology, Chonnam National University Hwasun Hospital, Jeollanam-do, Gwangju, Korea.
  • Kusumawidjaja G; Department of Radiation Oncology, Jeonbuk National University Hospital, Jeonju, Korea.
  • Lim F; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Cho WK; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Kim H; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Choi DH; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Park W; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Radiat Oncol ; 17(1): 186, 2022 Nov 16.
Article em En | MEDLINE | ID: mdl-36384804
ABSTRACT

BACKGROUND:

The Korean Radiation Oncology Group (KROG) 19 - 09 prospective cohort study aims to determine the effect of regional nodal irradiation on regional recurrence rates in ypN0 breast cancer patients. Dosimetric variations between radiotherapy (RT) plans of participating institutions may affect the clinical outcome of the study. We performed this study to assess inter-institutional dosimetric variations by dummy run.

METHODS:

Twelve participating institutions created RT plans for four clinical scenarios using computed tomography images of two dummy cases. Based on a reference structure set, we analyzed dose-volume histograms after collecting the RT plans.

RESULTS:

We found variations in dose distribution between institutions, especially in the regional nodal areas. Whole breast and regional nodal irradiation (WBI + RNI) plans had lower inter-institutional agreement and similarity for 95% isodose lines than WBI plans. Fleiss's kappa values, which were used to measure inter-institutional agreement for the 95% isodose lines, were 0.830 and 0.767 for the large and medium breast WBI plans, respectively, and 0.731 and 0.679 for the large and medium breast WBI + RNI plans, respectively. There were outliers in minimum dose delivered to 95% of the structure (D95%) of axillary level 1 among WBI plans and in D95% of the interpectoral region and axillary level 4 among WBI + RNI plans.

CONCLUSION:

We found inter-institutional and inter-case variations in radiation dose delivered to target volumes and organs at risk. As KROG 19 - 09 is a prospective cohort study, we accepted the dosimetric variation among the different institutions. Actual patient RT plan data should be collected to achieve reliable KROG 19 - 09 study results.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: Asia Idioma: En Revista: Radiat Oncol Assunto da revista: NEOPLASIAS / RADIOTERAPIA Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: Asia Idioma: En Revista: Radiat Oncol Assunto da revista: NEOPLASIAS / RADIOTERAPIA Ano de publicação: 2022 Tipo de documento: Article